Securities code: 000403 securities abbreviation: Pacific Shuanglin Bio-Pharmacy Co.Ltd(000403) Announcement No.: 2022-002 Pacific Shuanglin Bio-Pharmacy Co.Ltd(000403)
Announcement on the implementation of the reduction plan by shareholders holding more than 5% and the cumulative reduction of shares reaches 1%
Shenzhen shipping Health Technology Co., Ltd., a shareholder holding more than 5%, guarantees the authenticity of the information disclosure
True, accurate and complete, without false records, misleading statements or major omissions.
The company and all members of the board of directors guarantee that the contents of the announcement are consistent with the information provided by the information disclosure obligor
To.
Shenzhen shipping Health Technology Co., Ltd. (hereinafter referred to as "shipping health"), a shareholder holding more than 5% of the shares of Pacific Shuanglin Bio-Pharmacy Co.Ltd(000403) (hereinafter referred to as "the company"), plans to reduce all the shares of the company by means of centralized bidding transaction, block transaction and agreement transfer due to its own operating capital needs. For details, see the company's announcement on May 13, 2021 On November 12, 2021, on the securities times and cninfo (www.cn. Info. Com. CN.) The pre disclosure announcement of Pacific Shuanglin Bio-Pharmacy Co.Ltd(000403) on the share reduction plan of shareholders holding more than 5% (Announcement No.: 2021-055, 2021-097) disclosed.
The company received the notification letter issued by shipping health on January 12, 2022. Shipping health has reduced its holdings of 7.2 million shares of the company's tradable shares without sale conditions through block trading from December 29, 2021 to January 10, 2022, accounting for 0.9826% of the company's total share capital.
On July 15, 2021, September 14, 2021, October 8, 2021, October 20, 2021 and December 30, 2021, the company has published on the securities times and http://www.cn.info.com.cn The announcement of pais Shuanglin biopharmaceutical Co., Ltd. on the implementation of the reduction plan by shareholders holding more than 5% and the cumulative reduction of shares reaches 1% (Announcement No.: 2021-073, 2021-086, 2021-092, 2021-095 and 2021-106) has been disclosed. Up to now, shipping health has reduced 43751578 shares, accounting for 5.97% of the total share capital of the company.
1、 Shareholder reduction
Shareholder name reduction method reduction time reduction number of shares (shares) reduction proportion (%)
Bulk trading of shipping health from December 29, 2021 to January 10, 2022 7.2 million 0.9826%
Centralized bidding from December 29, 2021 to January 10, 2022 0%
Total - 7200000 0.9826%
2、 Details of changes in shares
1. Basic information
Information disclosure obligor: Shenzhen shipping Health Technology Co., Ltd
Address: Room 201, building a, No. 1, Qianwan 1st Road, Qianhai Shenzhen Hong Kong cooperation zone, Shenzhen
Changes in equity from December 29, 2021 to January 10, 2022
Stock abbreviation Pacific Shuanglin Bio-Pharmacy Co.Ltd(000403) stock code 000403
Change type increase □ decrease √ concerted action □ none √
Whether it is the largest shareholder or actual controller yes □ no √
2. Changes in equity
Shareholder name share type number of shares (shares) reduction proportion (%)
Shipping Health A shares 7200000 0.9826%
Total 7200000 0.9826%
Centralized trading through stock exchange □
The way of this equity change is through the block trading of the stock exchange √
Others □ (please specify)
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Shares held before this change shares held after this change
Name of shareholder and nature of shares
Proportion of shares (shares) to total share capital (%)
Total shares held: 54917201 7.494% 47717201 6.512%
Shipping health, including: unlimited bars 54917201 7.494% 47717201 6.512%
Piece shares
Shares with limited sales conditions ----
4. Implementation of commitments, plans, etc
Yes √ no □
On May 12, 2021, Shenzhen shipping Health Technology Co., Ltd. issued the notification letter on whether this change of share reduction plan is for performance, and plans to reduce its 91468779 shares through block trading, commitment, intention, planned centralized bidding trading and agreement transfer within six months after 15 trading days from the date of disclosure announcement.
On November 12, 2021, the company again issued the notification letter of share reduction plan, which intends to reduce its 61717201 shares through block trading, centralized bidding trading and agreement transfer within six months after 15 trading days from the date of disclosure and announcement.
Does this change violate the license
Securities Law on acquisition management of listed companies yes □ no √
Measures and other laws and administrative regulations. If yes, please explain the specific situation, rectification plan and treatment measures of violations.
Provisions of departmental rules, normative documents and business rules of the exchange 5 Shares with restricted voting rights
According to Article 63 of the securities law, yes □ no √
If so, please specify the proportion of the corresponding number of shares in the share capital of the existing listed company.
Voting shares 6 Documents for future reference 1. Details of shareholding changes of China Securities Depository and Clearing Co., Ltd. □
2. Relevant written commitment documents □
3. Written opinions of lawyers □
4. Other documents required by SZSE √
It is hereby announced.
Pacific Shuanglin Bio-Pharmacy Co.Ltd(000403)
Board of directors
January 13, 2002
